ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma

Jiang, Aimin; Luo, Peng; Chen, Ming; Fang, Yu; Liu, Bing; Wu, Zhenjie; Qu, Le; Wang, Anbang*; Wang, Linhui*; Cai, Chen*南方医科大学; 南京大学
Cell and Bioscience2022-12-29DOI: 10.1186/s13578-022-00948-7
5被引11阅读
引用收藏
分享

摘要

Rationale: Recent research has indicated that cuprotosis, or copper induced cell death, is a novel type of cell death that could be utilized as a new weapon for cancer management. However, the characteristics and implications of such signatures in cancers, especially in clear cell renal cell cancer (ccRCC), remain elusive. Methods: Expression, methylation, mutation, clinical information, copy number variation, functional implication, and drug sensitivity data at the pan-cancer level were collected from The Cancer Genome Atlas. An unsupervised clustering algorithm was applied to decipher ccRCC heterogeneity. Immune microenvironment construction, immune therapy response, metabolic pattern, and cancer progression signature between subgroups were also investigated. Results: Cuprotosis related genes were specifically downregulated in various cancer tissues compared with normal tissues and were correlated with hypermethylation and copy number variation. Cuprotosis scores were also dysregulated in tumor tissues, and we found that such a signature could positively regulate oxidative phosphorylation and Myc and negatively regulate epithelial mesenchymal translation and myogenesis pathways. CPCS1 (cuprotosis scores high) and CPCS2 (cuprotosis scores low) in ccRCC displayed distinctive clinical profiles and biological characteristics; the CPCS2 subtype had a higher clinical stage and a worse prognosis and might positively regulate cornification and epidermal cell differentiation to fuel cancer progression. CPCS2 also displayed a higher tumor mutation burden and low tumor stemness index, while it led to a low ICI therapy response and dysfunctional tumor immunity state. The genome-copy numbers of CPCS2, including arm- gain and arm- loss, were higher than those of CPCS1. The prognostic model constructed based on subgroup biomarkers exerted satisfactory performance in both the training and validation cohorts. In addition, overexpression of the copper death activator DLAT suppressed the malignant ability, including cell migration and proliferation, of renal cell lines in vitro and in vivo. Finally, activation of cuprotosis in tumors could enhance antitumor immunity through dsDNA-cGAS-STING signaling in ccRCC. Conclusion: The activation of cuprotosis might function as a promising approach among multiple cancers. The cuprotosis related signatures could reshape tumor immunity in the ccRCC microenvironment via cGAS-STING signal, thus activating tumor antigen-presenting process. Upregulation of DLAT expression in ccRCC cell lines could reactivate the copper death pattern and be treated as a suitable target for ccRCC.

学科与关键词

关键词
Copper induced cell deathPan-cancerClear cell renal cell carcinomaMolecular subtypesTumor immunity
相关
加载中…
  • The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
    Zhang, Lishuo; Di, Longjiang; Liu, Jinhui; Lei, Xianli; Gu, Maoli; Zhang, Wenjing*; Wang, Yufu*Frontiers in Genetics, 2023, 14: 1039813.
  • Role of copper ionophore-induced death in immune microenvironment and clinical prognosis of ccRCC: An integrated analysis
    Xia, Shunyao; Jia, Haixing; Qian, Zhipeng; Xiu, Youcheng*Frontiers in Genetics, 2022, 13: 994999.被引 2
  • Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer
    Zhou, Cankun; Li, Chaomei; Zheng, Yuhua*; Huang, Xiaobin*Frontiers in Oncology, 2022, 12: 934076.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell and Bioscience
发表日期
2022-12-29
卷期
第 12 卷, 第 1 期
页码
209
DOI
10.1186/s13578-022-00948-7
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; [81902560]; [81730073]; [81872074]

作者

  • J

    Jiang, Aimin (第一作者)

    second mil med univ

  • L

    Luo, Peng

    southern med univ

查看全部 10 位作者收起作者
  • C

    Chen, Ming

    changzheng hosp · second mil med univ

  • F

    Fang, Yu

    second mil med univ

  • L

    Liu, Bing

    second mil med univ

  • W

    Wu, Zhenjie

    second mil med univ

  • Q

    Qu, Le

    nanjing univ

  • W

    Wang, Anbang (通讯)

    changzheng hosp · second mil med univ

  • W

    Wang, Linhui (通讯)

    second mil med univ

  • C

    Cai, Chen (通讯)

    second mil med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417